'Consolidated
net sales (including other operating income) of Advanced Enzyme Technologies
has increased 4.92% to Rs 154.52 crore. The
total revenue from operations grew by 5% on YoY basis and de-grew by 2% on QoQ
basis. The revenue from human nutrition
segment increased by 2% to Rs 101.2 crore in Q1FY25 as compared to Rs 99.4 crore
in Q1FY24. This growth is on account of Probiotics and Nutrition business. The
Animal nutrition delivered a growth of 9% to Rs 17.2 crore in Q1FY25 as against
Rs 15.8 crore in Q1FY24. The Bio-Processing segment outperformed by 12% during
the quarter and accounted for Rs 25.1 crore in Q1FY25 as compared to Rs 22.4 crore
in Q1FY24. In this segment, food business grew by 6% to Rs 19.6 crore on YoY
basis during Q1FY25. The Non-Food business grew by 43% to stood at Rs 5.5 crore
during the quarter. The specialized manufacturing segment contributed 7% in the
pie which is around Rs 11.0 crore to the revenue during the quarter, an...
Pleaselogin & subscribe to view the full report.
More Reports
|
|